rs139265251

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 4P and 13B. PM1PM5BP4_StrongBP6BS1BS2

The NM_000377.3(WAS):​c.413G>A​(p.Arg138Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000718 in 1,182,649 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 269 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R138W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00072 ( 0 hom., 26 hem., cov: 23)
Exomes 𝑓: 0.00072 ( 0 hom. 243 hem. )

Consequence

WAS
NM_000377.3 missense

Scores

1
3
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3O:1

Conservation

PhyloP100: -0.126

Publications

4 publications found
Variant links:
Genes affected
WAS (HGNC:12731): (WASP actin nucleation promoting factor) The Wiskott-Aldrich syndrome (WAS) family of proteins share similar domain structure, and are involved in transduction of signals from receptors on the cell surface to the actin cytoskeleton. The presence of a number of different motifs suggests that they are regulated by a number of different stimuli, and interact with multiple proteins. Recent studies have demonstrated that these proteins, directly or indirectly, associate with the small GTPase, Cdc42, known to regulate formation of actin filaments, and the cytoskeletal organizing complex, Arp2/3. Wiskott-Aldrich syndrome is a rare, inherited, X-linked, recessive disease characterized by immune dysregulation and microthrombocytopenia, and is caused by mutations in the WAS gene. The WAS gene product is a cytoplasmic protein, expressed exclusively in hematopoietic cells, which show signalling and cytoskeletal abnormalities in WAS patients. A transcript variant arising as a result of alternative promoter usage, and containing a different 5' UTR sequence, has been described, however, its full-length nature is not known. [provided by RefSeq, Jul 2008]
WAS Gene-Disease associations (from GenCC):
  • Wiskott-Aldrich syndrome
    Inheritance: XL, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • X-linked severe congenital neutropenia
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • thrombocytopenia 1
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 5 uncertain in NM_000377.3
PM5
Other missense variant is known to change same aminoacid residue: Variant chrX-48685786-G-C is described in ClinVar as Pathogenic. ClinVar VariationId is 495847.Status of the report is criteria_provided_single_submitter, 1 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.01782313).
BP6
Variant X-48685786-G-A is Benign according to our data. Variant chrX-48685786-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 135414.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000723 (81/112015) while in subpopulation AMR AF = 0.00104 (11/10577). AF 95% confidence interval is 0.000765. There are 0 homozygotes in GnomAd4. There are 26 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 81 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WASNM_000377.3 linkc.413G>A p.Arg138Gln missense_variant Exon 4 of 12 ENST00000376701.5 NP_000368.1 P42768A0A024QYX8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WASENST00000376701.5 linkc.413G>A p.Arg138Gln missense_variant Exon 4 of 12 1 NM_000377.3 ENSP00000365891.4 P42768

Frequencies

GnomAD3 genomes
AF:
0.000723
AC:
81
AN:
111963
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000651
Gnomad AMI
AF:
0.0176
Gnomad AMR
AF:
0.00104
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000844
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000978
Gnomad OTH
AF:
0.000668
GnomAD2 exomes
AF:
0.000451
AC:
61
AN:
135281
AF XY:
0.000491
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000361
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000295
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000868
Gnomad OTH exome
AF:
0.000542
GnomAD4 exome
AF:
0.000717
AC:
768
AN:
1070634
Hom.:
0
Cov.:
33
AF XY:
0.000697
AC XY:
243
AN XY:
348606
show subpopulations
African (AFR)
AF:
0.0000782
AC:
2
AN:
25585
American (AMR)
AF:
0.000423
AC:
13
AN:
30727
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18958
East Asian (EAS)
AF:
0.000352
AC:
10
AN:
28413
South Asian (SAS)
AF:
0.0000390
AC:
2
AN:
51295
European-Finnish (FIN)
AF:
0.000129
AC:
5
AN:
38701
Middle Eastern (MID)
AF:
0.000487
AC:
2
AN:
4106
European-Non Finnish (NFE)
AF:
0.000853
AC:
706
AN:
827814
Other (OTH)
AF:
0.000622
AC:
28
AN:
45035
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
41
83
124
166
207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000723
AC:
81
AN:
112015
Hom.:
0
Cov.:
23
AF XY:
0.000760
AC XY:
26
AN XY:
34207
show subpopulations
African (AFR)
AF:
0.0000649
AC:
2
AN:
30812
American (AMR)
AF:
0.00104
AC:
11
AN:
10577
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2645
East Asian (EAS)
AF:
0.000847
AC:
3
AN:
3544
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2703
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6131
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.000978
AC:
52
AN:
53187
Other (OTH)
AF:
0.000659
AC:
1
AN:
1517
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000797
Hom.:
7
Bravo
AF:
0.000748
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00208
AC:
6
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00134
AC:
9
ExAC
AF:
0.000434
AC:
51

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Wiskott-Aldrich syndrome Uncertain:1
Aug 19, 2020
St. Jude Molecular Pathology, St. Jude Children's Research Hospital
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

WAS-related disorder Benign:1
Jun 03, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Wiskott-Aldrich syndrome;C1839163:Thrombocytopenia 1;C1845987:X-linked severe congenital neutropenia Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Feb 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

WAS: BS2 -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.059
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
8.7
DANN
Benign
0.92
DEOGEN2
Uncertain
0.48
T;D
FATHMM_MKL
Benign
0.021
N
LIST_S2
Benign
0.66
T;T
M_CAP
Pathogenic
0.49
D
MetaRNN
Benign
0.018
T;T
MetaSVM
Uncertain
0.14
D
MutationAssessor
Benign
0.16
.;N
PhyloP100
-0.13
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-1.7
N;N
REVEL
Uncertain
0.36
Sift
Benign
0.32
T;T
Sift4G
Benign
0.56
T;T
Polyphen
0.27
.;B
Vest4
0.13
MVP
0.81
MPC
0.68
ClinPred
0.015
T
GERP RS
-3.7
Varity_R
0.082
gMVP
0.68
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139265251; hg19: chrX-48544175; COSMIC: COSV100939526; COSMIC: COSV100939526; API